In TS, the broader pan-macrophage marker CD68 had a better prognostic impact on BCSS compared to the anti-inflammatory CD163 marker, which is surprising since CD163 also seems to stain cells of myeloid origin other than TAMs. Here, CD68 is linked to Timothy syndrome.